This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Cathepsin
From Proteopedia
(Difference between revisions)
| Line 46: | Line 46: | ||
* Cathepsin-B mature | * Cathepsin-B mature | ||
| - | **[[ | + | **[[2ipp]], [[1huc]] – hMCTSB<br /> |
| - | + | ||
| - | + | ||
**[[3k9m]] – hMCTSB+stefin A<br /> | **[[3k9m]] – hMCTSB+stefin A<br /> | ||
| - | **[[3ai8]] – hMCTSB + antibiotic | + | **[[3ai8]] – hMCTSB + antibiotic<br /> |
| - | + | ||
**[[3cbj]], [[3cbk]] – hMCTSB (mutant)+chagasin<br /> | **[[3cbj]], [[3cbk]] – hMCTSB (mutant)+chagasin<br /> | ||
**[[5mbl]], [[5mbm]] – hMCTSB + darpin <br /> | **[[5mbl]], [[5mbm]] – hMCTSB + darpin <br /> | ||
| Line 62: | Line 59: | ||
**[[1cpj]] - rMCTSB (mutant)<br /> | **[[1cpj]] - rMCTSB (mutant)<br /> | ||
**[[1cte]] - rMCTSB+pyrimidine inhibitor<br /> | **[[1cte]] - rMCTSB+pyrimidine inhibitor<br /> | ||
| + | **[[3hhi]] – TbCTSB (mutant) residues 23-340+CA074 <br /> | ||
| + | **[[3mor]] - TbCTSB residues 23-340<br /> | ||
| + | **[[3qsd]], [[3s3q]], [[3s3r]] - CTSB (mutant) residues 87-340+ inhibitor – ''Schistosoma mansoni''<br /> | ||
* Cathepsin-C mature or [[Dipeptidyl peptidase]]-I | * Cathepsin-C mature or [[Dipeptidyl peptidase]]-I | ||
| - | **[[2djf]], [[2djg]], [[4oel]], [[4oem]] – hMCTSC + dipeptide<br /> | ||
| - | **[[1jqp]] – rMCTSC <br /> | ||
**[[1k3b]] – hMCTSC <br /> | **[[1k3b]] – hMCTSC <br /> | ||
| + | **[[2djf]], [[2djg]], [[4oel]], [[4oem]] – hMCTSC + dipeptide<br /> | ||
**[[3pdf]], [[4cdc]], [[4cdd]], [[4cde]], [[4cdf]] – hMCTSC + inhibitor<br /> | **[[3pdf]], [[4cdc]], [[4cdd]], [[4cde]], [[4cdf]] – hMCTSC + inhibitor<br /> | ||
| + | **[[1jqp]] – rMCTSC <br /> | ||
* Cathepsin-D mature | * Cathepsin-D mature | ||
| Line 75: | Line 75: | ||
**[[1lyb]] - hMCTSD+pepstatin<br /> | **[[1lyb]] - hMCTSD+pepstatin<br /> | ||
**[[4obz]], [[4oc6]], [[4od9]] – hMCTSD + non-peptidic inhibitor<br /> | **[[4obz]], [[4oc6]], [[4od9]] – hMCTSD + non-peptidic inhibitor<br /> | ||
| + | **[[5ux4]] – rMCTSD + inhibitor<br /> | ||
* Cathepsin-E mature | * Cathepsin-E mature | ||
| Line 89: | Line 90: | ||
**[[1au8]], [[1cgh]] - hMCTSG +phosphonate inhibitor<br /> | **[[1au8]], [[1cgh]] - hMCTSG +phosphonate inhibitor<br /> | ||
**[[1t32]] - hMCTSG +piperidine inhibitor | **[[1t32]] - hMCTSG +piperidine inhibitor | ||
| + | |||
| + | *Procathepsin-H | ||
| + | |||
| + | **[[6czk]] – hPCTSH <br /> | ||
| + | **[[6czs]] – hPCTSH (mutant) <br /> | ||
* Cathepsin-H mature | * Cathepsin-H mature | ||
| Line 102: | Line 108: | ||
**[[4n79]], [[5tun]], [[4yva]] – hMCTSK<br /> | **[[4n79]], [[5tun]], [[4yva]] – hMCTSK<br /> | ||
| - | **[[5jh3]] – hMCTSK (mutant) | + | **[[5jh3]], [[5z5o]] – hMCTSK (mutant) <br /> |
| - | + | ||
**[[3o1g]], [[3n3g]], [[2r6n]], [[1bgo]], [[3kwz]], [[3kx1]], [[3o0u]] – hMCTSK+ pyrimidine inhibitor<br /> | **[[3o1g]], [[3n3g]], [[2r6n]], [[1bgo]], [[3kwz]], [[3kx1]], [[3o0u]] – hMCTSK+ pyrimidine inhibitor<br /> | ||
**[[5qby]], [[5qbv]] – hMCTSK (mutant) + pyrimidine inhibitor<br /> | **[[5qby]], [[5qbv]] – hMCTSK (mutant) + pyrimidine inhibitor<br /> | ||
| Line 122: | Line 127: | ||
**[[1au2]] - hMCTSK+ propanone inhibitor<br /> | **[[1au2]] - hMCTSK+ propanone inhibitor<br /> | ||
**[[1atk]] – hMCTSK+guanidine inhibitor<br /> | **[[1atk]] – hMCTSK+guanidine inhibitor<br /> | ||
| - | **[[1vsn]], [[5j94]], [[4x6h]], [[4x6i]] - hMCTSK+ inhibitor<br /> | + | **[[1vsn]], [[5j94]], [[4x6h]], [[4x6i]], [[6qbs]] - hMCTSK+ inhibitor<br /> |
| + | **[[6ash]] – hMCTSK (mutant) + inhibitor<br /> | ||
**[[2ato]] – hMCTSK+myocrisin<br /> | **[[2ato]] – hMCTSK+myocrisin<br /> | ||
**[[1u9v]], [[1u9x]], [[1mem]] – hMCTSK+piperazine inhibitor<br /> | **[[1u9v]], [[1u9x]], [[1mem]] – hMCTSK+piperazine inhibitor<br /> | ||
| Line 131: | Line 137: | ||
**[[2ftd]] – MCTSK+azepan inhibitor – ''Macaca mulatta''<br /> | **[[2ftd]] – MCTSK+azepan inhibitor – ''Macaca mulatta''<br /> | ||
**[[2f7d]] – MCTSK (mutant)+nitrile inhibitor - rabbit<br /> | **[[2f7d]] – MCTSK (mutant)+nitrile inhibitor - rabbit<br /> | ||
| + | **[[5t6u]] – mMCTSK<br /> | ||
| + | **[[6bki]] – mMCTSK (mutant) <br /> | ||
*Procathepsin-L | *Procathepsin-L | ||
| Line 139: | Line 147: | ||
* Cathepsin-L mature | * Cathepsin-L mature | ||
| - | **[[3f75]] – MCTSL +CTSL propeptide – ''Toxoplasma gondii''<br /> | ||
| - | **[[2p86]] – TbMCTSL +K11002<br /> | ||
| - | **[[2nqd]] - CTSL residues 1-220 (mutant)+chagasin – ''Trypanosoma cruzi''<br /> | ||
**[[4axl]] – hMCTSL catalytic domain<br /> | **[[4axl]] – hMCTSL catalytic domain<br /> | ||
**[[4axm]] – hMCTSL catalytic domain + inhibitor<br /> | **[[4axm]] – hMCTSL catalytic domain + inhibitor<br /> | ||
**[[1mhw]] – hMCTSL +tripeptide<br /> | **[[1mhw]] – hMCTSL +tripeptide<br /> | ||
**[[1icf]] – hMCTSL +MHC class II fragment<br /> | **[[1icf]] – hMCTSL +MHC class II fragment<br /> | ||
| + | **[[3f75]] – MCTSL +CTSL propeptide – ''Toxoplasma gondii''<br /> | ||
| + | **[[2p86]] – TbMCTSL +K11002<br /> | ||
| + | **[[2nqd]] - CTSL residues 1-220 (mutant)+chagasin – ''Trypanosoma cruzi''<br /> | ||
* Procathepsin-L1 | * Procathepsin-L1 | ||
| Line 163: | Line 171: | ||
**[[3kse]] – hMCTSL1 (mutant)+stefin<br /> | **[[3kse]] – hMCTSL1 (mutant)+stefin<br /> | ||
**[[4axm]], [[5mae]], [[5maj]], [[5f02]], [[3bc3]], [[3of9]] – hMCTSL1 catalytic domain + inhibitor<br /> | **[[4axm]], [[5mae]], [[5maj]], [[5f02]], [[3bc3]], [[3of9]] – hMCTSL1 catalytic domain + inhibitor<br /> | ||
| + | **[[6f06]], [[6ezx]], [[6ezp]] – hMCTSL1 catalytic domain + carboxamide inhibitor<br /> | ||
* Cathepsin-L2 mature | * Cathepsin-L2 mature | ||
Revision as of 08:50, 30 April 2019
| |||||||||||
3D Structures of Cathepsin
Updated on 30-April-2019
References
- ↑ Nomura T, Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest. 2005 Feb;52(1-2):1-9. PMID:15751268
- ↑ Mirkovic B, Renko M, Turk S, Sosic I, Jevnikar Z, Obermajer N, Turk D, Gobec S, Kos J. Novel Mechanism of Cathepsin B Inhibition by Antibiotic Nitroxoline and Related Compounds. ChemMedChem. 2011 May 20. doi: 10.1002/cmdc.201100098. PMID:21598397 doi:10.1002/cmdc.201100098
